Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK200 at Bernstein SocGen Group, 'why's it still a value trap in our view'
Bernstein SocGen Group analyst Justin Smith raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK200.00 (from DKK175.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)